Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study

Venkateswarlu, Divi
January 2010
BMC Structural Biology;2010, Vol. 10, p7
Academic Journal
Background: Human blood coagulation factor VIII (fVIII) is a large plasma glycoprotein with sequential domain arrangement in the order A1-a1-A2-a2-B-a3-A3-C1-C2. The A1, A2 and A3 domains are interconnected by long linker peptides (a1, a2 and a3) that possess the activation sites. Proteolysis of fVIII zymogen by thrombin or factor Xa results in the generation of the activated form (fVIIIa) which serves as a critical co-factor for factor IXa (fIXa) enzyme in the intrinsic coagulation pathway. Results: In our efforts to elucidate the structural differences between fVIII and fVIIIa, we developed the solution structural models of both forms, starting from an incomplete 3.7 Ã… X-ray crystal structure of fVIII zymogen, using explicit solvent MD simulations. The full assembly of B-domainless single-chain fVIII was built between the A1-A2 (Ala1-Arg740) and A3-C1-C2 (Ser1669-Tyr2332) domains. The structural dynamics of fVIII and fVIIIa, simulated for over 70 ns of time scale, enabled us to evaluate the integral motions of the multi-domain assembly of the cofactor and the possible coordination pattern of the functionally important calcium and copper ion binding in the protein. Conclusions: MD simulations predicted that the acidic linker peptide (a1) between the A1 and A2 domains is largely flexible and appears to mask the exposure of putative fIXa enzyme binding loop (Tyr555-Asp569) region in the A2 domain. The simulation of fVIIIa, generated from the zymogen structure, predicted that the linker peptide (a1) undergoes significant conformational reorganization upon activation by relocating completely to the A1- domain. The conformational transition led to the exposure of the Tyr555-Asp569 loop and the surrounding region in the A2 domain. While the proposed linker peptide conformation is predictive in nature and warrants further experimental validation, the observed conformational differences between the zymogen and activated forms may explain and support the large body of experimental data that implicated the critical importance of the cleavage of the peptide bond between the Arg372 and Ser373 residues for the full co-factor activity of fVIII.


Related Articles

  • Evaluation of the association between FGBrs1800790 and plasma fibrinogen levels. Mashayekhi, A.; Shahbazi, Sh. // Scientific Journal of Iranian Blood Transfusion Organization;Spring2014, Vol. 11 Issue 1, p48 

    Background and Objectives Fibrinogen, coagulation factor 1, is a soluble plasma glycoprotein which converts thrombin to fibrin fibers in the coagulation cascade. Various polymorphisms located on beta chain gene, FGB, have been studied. The promoter - G455A (rs1800790) polymorphism had been shown...

  • In ECAT veritas? Reber, G; Meijer, P // Lupus;Jul2012, Vol. 21 Issue 7, p722 

    The laboratory criteria of the antiphospholipid syndrome include one coagulation assay (lupus anticoagulant [LA]) and two solid phase assays (anticardiolipin [aCL] and anti-ß2glycoprotein I antibodies [aß2GPI]). External quality control (EQC) surveys show that negative and clearly positive...

  • Proteolysis of Human Thrombin Generates Novel Host Defense Peptides. Papareddy, Praveen; Rydengård, Victoria; Pasupuleti, Mukesh; Walse, Björn; Mörgelin, Matthias; Chalupka, Anna; Malmsten, Martin; Schmidtchen, Artur // PLoS Pathogens;Apr2010, Vol. 6 Issue 4, p1 

    The coagulation system is characterized by the sequential and highly localized activation of a series of serine proteases, culminating in the conversion of fibrinogen into fibrin, and formation of a fibrin clot. Here we show that C-terminal peptides of thrombin, a key enzyme in the coagulation...

  • Human Plasma Kallikrein-Kinin System: Physiological and Biochemical Parameters. Bryant, J. W.; Shariat-Madar, Z. // Cardiovascular & Hematological Agents in Medicinal Chemistry;2009, Vol. 7 Issue 3, p234 

    The plasma kallikrein-kinin system (KKS) plays a critical role in human physiology. The KKS encompasses coagulation factor XII (FXII), the complex of prekallikrein (PK) and high molecular weight kininogen (HK). The conversion of plasma prekallikrein to kallikrein by the activated FXII and in...

  • Peptide analogues of 1811—1818 loop of the A3 subunit of the light chain A3-C1—C2 of FVIII of blood coagulation: biological evaluation. Patsialas, K.; Koutsas, C.; Makris, P.; Liakopoulou-Kyriakides, Maria // Amino Acids;Jul2010, Vol. 39 Issue 2, p481 

    Factor VIII, the plasma protein deficient or defective in individuals with hemophilia A, is a critical member of the blood coagulation cascade. Recent studies have identified the FVIII light chain region Glu1811-Lys1818 as being involved in FIXa binding and in the assembly of the FX-activating...

  • Treatment of Afibrinogenemia in a Chihuahua. Chambers, Gregory // Journal of the American Animal Hospital Association;Jan/Feb2013, Vol. 49 Issue 1, p70 

    The article describes the case of afibrinogenemia in a Chihuahua in which bleeding persisted two days after standard plasma transfusion levels were administered and prothrombin time (PT) and activated partial thromboplastin time (aPTT) levels had normalized. It notes the similarity of the...

  • Elevation of plasma tissue factor levels in patients with severe acute pancreatitis. Sawa, Hidehiro; Ueda, Takashi; Takeyama, Yoshifumi; Yasuda, Takeo; Matsumura, Naoki; Nakajima, Takahiro; Ajiki, Tetsuo; Fujino, Yasuhiro; Suzuki, Yasuyuki; Kuroda, Yoshikazu // Journal of Gastroenterology;Jun2006, Vol. 41 Issue 6, p575 

    Background. Coagulative disorders are known to occur in severe acute pancreatitis (SAP), and they are related to its severity and organ dysfunctions. Tissue factor (TF) is a transmembrane glycoprotein that activates the extrinsic pathway of the blood coagulation cascade. Plasma TF levels...

  • The risk of early mortality of polytrauma patients associated to ISS, NISS, APACHE II values and prothrombin time. Mica, Ladislav; Rufibach, Kaspar; Keel, Marius; Trentz, Otmar // Journal of Trauma Management & Outcomes;2013, Vol. 7 Issue 1, p1 

    Background: The early hemodynamic normalization of polytrauma patients may lead to better survival outcomes. The aim of this study was to assess the diagnostic quality of trauma and physiological scores from widely used scoring systems in polytrauma patients. Methods: In total, 770 patients with...

  • Plasma thrombomodulin levels in patients with Behçet's disease. Düzgün, Nurşen; Ayaşlio&gcaron;lu, Ergin; Tutkak, Hüseyin; Şahin, Mehmet; Aydintu&gcaron;, Olcay; Ölmez, Ümit // Rheumatology International;May2003, Vol. 23 Issue 3, p130 

    The plasma levels of thrombomodulin in 54 patients with Behçet's disease (BD) and 20 healthy control subjects were studied. The mean thrombomodulin (TM) level was significantly higher in active BD patients than in inactive patients and healthy controls (P<0.001 and <0.01, respectively)....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics